Isolation and characterization of novel giant Stenotrophomonas maltophilia phage phiSMA5

Hsiao-Chuan Chang1, Chiy-Rong Chen, Juey-Wen Lin

  • 1Institute of Molecular Biology, National Chung Hsing University, Taichung 402, Taiwan.

Insights

Researchers isolated eight Stenotrophomonas maltophilia phages from clinical samples. One phage, phiSMA5, was characterized, showing potential for phage therapy against antibiotic-resistant bacteria.

Area of Science:

  • Microbiology
  • Bacteriology
  • Virology

Background:

  • Stenotrophomonas maltophilia is a prevalent opportunistic pathogen causing nosocomial infections.
  • Antibiotic resistance in S. maltophilia necessitates alternative therapeutic strategies like phage therapy.

Purpose of the Study:

  • To isolate and characterize bacteriophages targeting Stenotrophomonas maltophilia.
  • To evaluate the potential of isolated phages for phage therapy applications.

Main Methods:

  • Isolation of phages from clinical samples (patient specimens, devices, wastewater).
  • Phage grouping based on host range and DNA digestion patterns.
  • Characterization of phage phiSMA5 using electron microscopy, restriction enzyme analysis, pulsed-field gel electrophoresis, and SDS-PAGE.
  • N-terminal sequencing of virion proteins.

Main Results:

  • Eight S. maltophilia phages were isolated and classified into four groups.
  • Phage phiSMA5, resembling Myoviridae, possesses a 250 kb double-stranded DNA genome.
  • SDS-PAGE revealed 25 virion proteins, with some showing N-terminal cleavage.
  • phiSMA5 infected 61 out of 87 tested S. maltophilia strains.

Conclusions:

  • phiSMA5 is the first reported bacteriophage targeting Stenotrophomonas maltophilia.
  • Further phage isolation and characterization are crucial for developing effective phage therapy strategies against S. maltophilia.